148 related articles for article (PubMed ID: 29856034)
1. Disease Modification Through Trophic Factor Delivery.
Savolainen M; Emerich D; Kordower JH
Methods Mol Biol; 2018; 1780():525-547. PubMed ID: 29856034
[TBL] [Abstract][Full Text] [Related]
2. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
3. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
McBride JL; During MJ; Wuu J; Chen EY; Leurgans SE; Kordower JH
Exp Neurol; 2003 Jun; 181(2):213-23. PubMed ID: 12781994
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.
Wu Z; Parry M; Hou XY; Liu MH; Wang H; Cain R; Pei ZF; Chen YC; Guo ZY; Abhijeet S; Chen G
Nat Commun; 2020 Feb; 11(1):1105. PubMed ID: 32107381
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
[TBL] [Abstract][Full Text] [Related]
8. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
[TBL] [Abstract][Full Text] [Related]
9. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
[TBL] [Abstract][Full Text] [Related]
10. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
11. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
Franich NR; Fitzsimons HL; Fong DM; Klugmann M; During MJ; Young D
Mol Ther; 2008 May; 16(5):947-56. PubMed ID: 18388917
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
Jeon J; Kim W; Jang J; Isacson O; Seo H
Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
Ebert AD; Barber AE; Heins BM; Svendsen CN
Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
[TBL] [Abstract][Full Text] [Related]
14. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
Zuccato C; Ciammola A; Rigamonti D; Leavitt BR; Goffredo D; Conti L; MacDonald ME; Friedlander RM; Silani V; Hayden MR; Timmusk T; Sipione S; Cattaneo E
Science; 2001 Jul; 293(5529):493-8. PubMed ID: 11408619
[TBL] [Abstract][Full Text] [Related]
15. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
[TBL] [Abstract][Full Text] [Related]
16. Cellular Analysis of Silencing the Huntington's Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140/Q140 Mice.
Keeler AM; Sapp E; Chase K; Sottosanti E; Danielson E; Pfister E; Stoica L; DiFiglia M; Aronin N; Sena-Esteves M
J Huntingtons Dis; 2016 Oct; 5(3):239-248. PubMed ID: 27689620
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
Popovic N; Maingay M; Kirik D; Brundin P
Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
[TBL] [Abstract][Full Text] [Related]
18. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
[TBL] [Abstract][Full Text] [Related]
19. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
